-
Dr. Mark Muthiah: Exploration of Liver Fibrosis Reversal and Patient Clinical Management
Recently, the Combined GlHep&SHC 2024 was held in Singapore. This conference brings together elite scholars in the field of liver disease from around the world to discuss the latest developments, challenges, and opportunities in liver disease. Hepatology Digest invited Dr. Mark Muthiah from the National University Hospital, Singapore to conduct in-depth discussions on issues related…
-
Dr Ken Liu: New Technology for Hepatocellular Carcinoma Detection
The Combined GlHep&SHC 2024 was recently held in Singapore. This conference brings together elite scholars in the field of liver disease from around the world to discuss the latest developments, challenges, and opportunities in liver disease. Liver cancer is the third leading cause of cancer death worldwide, and hepatocellular carcinoma (HCC) is the most common…
-
Building a Health Defense Line, Focusing on China Anemia Day on August 18th: Caring for the Source of Life, Starting with Understanding Anemia
Understanding Anemia: The Invisible Health Challenge Anemia, in simple terms, refers to a reduction in the peripheral blood red blood cell (RBC) count below the normal range, a common clinical…
-
International Lung Cancer Conferenc | Dr. Huijuan Wang Reviews Perioperative Treatment Advances in NSCLC
The perioperative treatment of early-stage non-small cell lung cancer (NSCLC) has now entered the era of precision-targeted therapy and immunotherapy. At the NSCLC Medical Treatment Session of the International Lung Cancer Conference (CLC 2024) held from August 9-11, Dr. Huijuan Wang from Henan Cancer Hospital delivered a keynote speech titled “Advances in Perioperative Treatment of…
-
International Lung Cancer Conference | Dr. Panwen Tian: Exploration and Practice of Biomarkers in Lung Cancer Immunotherapy
The exploration of biomarkers in immunotherapy is constantly evolving, yet only a few have proven to effectively guide clinical decision-making. At the 2024 International Lung Cancer Conference (CLC 2024), held from August 9-11, Dr. Panwen Tian from West China Hospital of Sichuan University delivered a keynote speech titled “Thoughts and Exploration of Biomarkers in Lung…
-
2024 COMB丨Dr. Tao Sun: Advancements in HER2+ EBC Treatment—De-escalation Therapy and the Future of ctDNA Applications
In recent years, the field of breast cancer treatment has witnessed a series of innovative research developments, particularly in the treatment of HER2+ early breast cancer (EBC). Strategies such as “de-escalation,” “chemotherapy-free,” and “precision treatment” have become hot topics. At the 7th Oncology Precision Diagnosis and Treatment Conference and the 10th Breast Cancer Individualized Treatment…
-
2024 COMB丨Dr. Jiani Wang: Insights on the ADAPT Study and New Advances in Precision Treatment for HER2+ Breast Cancer
At the full-session management segment of the 7th Oncology Precision Diagnosis and Treatment Conference and the 10th Breast Cancer Individualized Treatment Conference (2024 COMB), Dr. Jiani Wang from the Cancer Hospital , Chinese Academy of Medical Sciences and Peking Union Medical College, along with three other breast cancer experts, engaged in a deep discussion on…
-
Dr Vincent Wong: Lean metabolic associated fatty liver disease from a clinical perspective
The Combined GlHep&SHC 2024 will be held in Singapore from July 25th to 28th, 2024. This conference brings together elite scholars in the field of liver disease from around the world to discuss the latest developments, challenges, and opportunities in liver disease. Hepatology Digest invited Dr Vincent Wong from The Chinese University of Hong Kong…
Connecting Medical Expertise through Media